Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
04/2001
04/03/2001US6210910 Inserting cells into microwells on individual fiber strands, optically coupling detector to strands, contacting with sample, and measuring response
04/03/2001US6210907 Chromatographic device includes pretreatment bands/layers which remove interferents, convert, and detect sample; and electrodes
04/03/2001US6210898 Using strip of porous material which transports sample liquid by capillary action to several unique capture reagents immobilized in discrete spaced apart spots, then determining binding of analyte at the spots
04/03/2001US6210897 Identification of canine leukocyte adhesion deficiency in dogs
04/03/2001US6210896 Polymer analysis by exposing units to electromagnetic radiation, a quencher source, or fluorescence excitation by using molecular motor to move polymer relative to agent, then detecting signals; sequencing nucleic acids
04/03/2001US6210895 Comparing concentration of heme oxygenase-1 or its nucleotide sequence in body fluid or non-neural tissue to control; reduction indicates alzheimer's disease, age-associated cognitive decline, creutzfeld-jacob disease, or other disease
04/03/2001US6210894 Method and apparatus for conducting an array of chemical reactions on a support surface
04/03/2001US6210893 Automated quantification of DNA strand breaks in intact cells
04/03/2001US6210891 Method of sequencing DNA
04/03/2001US6210889 Method for enrichment of fetal cells from maternal blood and use of same in determination of fetal sex and detection of chromosomal abnormalities
04/03/2001US6210888 Drug screening of enzyme inhibitors of cytidine deaminase, apobec-1 enzyme, by incubating with aminated nucleic acid substrate in presence or absence of compound and determining effect; treatment of atherosclerosis, obesity, hyperlipemia
04/03/2001US6210886 Method for diagnosing multiple myeloma by determining tumor rejection antigen precursors
04/03/2001US6210885 Modifying double stranded DNA to enhance separations by matched ion polynucleotide chromatography
04/03/2001US6210884 Specific, sensitive method by mixing primer with circles tethered to specific binding molecule for free rotation, incubating for hybridization, adding dna polymerase, incubating for replication; forms tandem sequence dna
04/03/2001US6210883 Compounds and methods for diagnosis of lung cancer
04/03/2001US6210881 Method for reducing inhibitors of nucleic acid hybridization
04/03/2001US6210880 Polymorphism analysis by nucleic acid structure probing with structure-bridging oligonucleotides
04/03/2001US6210879 Method for diagnosing schizophrenia
04/03/2001US6210878 Screening for presence of breast cancer cells in sample from human patient by contacting with hybridization probe which binds selectively to region of chromosome 20 having altered copy number, then detecting
04/03/2001US6210877 Prediction of coronary artery disease
04/03/2001US6210876 Nucleic acid primers and probes for detecting Chlamydia pneumoniae
04/03/2001US6210875 Detecting level of transcriptionally active human immunodeficiency virus in monocytes by exposing monocytes to oligonucleotide probe which binds to messenger rna and exposing to antibody, comparing, correlating over time
04/03/2001US6210682 Immunization against rotavirus infection or rotavirus disease by administering to a subject a peptide nsp4 114-135, a peptide nsp4 120-147, or a toxoid thereof are disclosed.
04/03/2001US6210675 Post-transfusional non-a non-b hepatitis viral polypeptide
04/03/2001US6210674 GreA from Staphylococcus aureus
04/03/2001US6210654 Jak kinases and regulation of cytokine signal transduction
04/03/2001US6210326 Microsensor for determination of glucose and other analysis in liquids based on affinity viscosimetry
04/03/2001CA2196795C Method for diagnosing a predisposition for breast and ovarian cancer
04/03/2001CA2153180C Interleukin 4 signal transducers and binding assays
04/03/2001CA2066234C Activation compounds and methods for nucleic acid sterilization
04/01/2001CA2319168A1 Hyperactive mutants of himar1 transposase and methods for using the same
03/2001
03/30/2001WO2003044525A1 Targeting cells having mad2 mutation for treatment and/or prevention of disease
03/30/2001WO2003042411A2 Use of mutations of mec-1 and its related genes in the identification of compounds for treatment of disease
03/30/2001WO2002090588A1 Interfering with telomere maintenance in treatment of diseases
03/30/2001CA2384139A1 Interfering with telomere maintenance in treatment of diseases
03/30/2001CA2380624A1 Mutation of mec-1 related genes in the treatment of disease
03/30/2001CA2283538A1 New hev antigenic peptide and methods
03/29/2001WO2001022092A2 Method to identify compounds which modulate fra-1 expression fils
03/29/2001WO2001022091A2 Method for determining the fertility of mammals, especially of humans
03/29/2001WO2001022090A1 Method for identifying compounds useful in the therapy of bone disorders
03/29/2001WO2001022089A1 HYBRIDIZATION SELF-REcOGNITION TYPE PROBE
03/29/2001WO2001022086A1 A high-throughput system for evaluating the clinical utility of molecular targets in tissue samples
03/29/2001WO2001021840A2 Indexing populations
03/29/2001WO2001021839A2 Gene expression profiles
03/29/2001WO2001021838A2 Three-dimensional microarray system for parallel genotyping of single nucleotide polymorphisms
03/29/2001WO2001021836A2 Molecules for diagnostics and therapeutics
03/29/2001WO2001021835A2 Method to determine the susceptibility of scrapie in sheep
03/29/2001WO2001021834A1 Polymorphism assay
03/29/2001WO2001021833A2 Assay for detection of human cftr allele variants using specific diagnostic primers
03/29/2001WO2001021832A1 Susceptibility gene for inflammatory bowel disease
03/29/2001WO2001021831A1 Method for identifying novel genes involved in the regulation of angiogenesis, study of said genes and use thereof for therapeutic purposes
03/29/2001WO2001021830A1 Nuclease inhibitor cocktail
03/29/2001WO2001021828A1 A pcam-1 marker protein, nucleic acid sequences encoding pcam-1 and immunoassays for detection of pcam-1
03/29/2001WO2001021827A1 Small volume biosensor for continuous analyte monitoring
03/29/2001WO2001021825A2 Novel enzymes which dehydrate glycerol
03/29/2001WO2001021815A1 Checkpoint gene associated cell cycle proteins, compositions and methods of use
03/29/2001WO2001021814A1 Heparanase-2, a member of the heparanase protein family
03/29/2001WO2001021813A1 Method and compositions for improved polynucleotide synthesis
03/29/2001WO2001021812A1 Phosphatases which activate map kinase pathways
03/29/2001WO2001021804A1 Chlamydia antigens and corresponding dna fragments and uses thereof
03/29/2001WO2001021799A1 Traf4 associated cell cycle proteins, compositions and methods of use
03/29/2001WO2001021797A1 Rgs10b, a g-protein regulator expressed in osteoclasts
03/29/2001WO2001021793A1 p21Cip1 REMEDIES FOR RHEUMATISM
03/29/2001WO2001021792A1 Transporter genes oatp-b, c, d and e
03/29/2001WO2001021784A2 Pcna-associated cell cycle proteins, compositions and methods of use
03/29/2001WO2001021772A2 Methods and microorganisms for production of panto-compounds
03/29/2001WO2001021771A2 Compositions and methods for inhibiting g2 cell cycle arrest and sensitizing cells to dna damaging agents
03/29/2001WO2001021758A2 Colorimetric test for agents that induce mitrochondrial dysfunction
03/29/2001WO2001021663A1 Pcna associated cell cycle proteins, compositions and methods of use
03/29/2001WO2001021662A1 Signal sequences for the production of leu-hirudine via secretion by e. coli in a culture medium
03/29/2001WO2001021658A1 32 human secreted proteins
03/29/2001WO2001021657A1 Novel protein, gene encoding the same and method of utilization thereof
03/29/2001WO2001021654A2 Syk kinase-associated cell cycle proteins, compositions and methods of use
03/29/2001WO2001021644A2 Wheat dp proteins and uses thereof
03/29/2001WO2001021635A2 Method for electrochemically detecting sequence-specific nucleic acid-oligomer hybridisation events
03/29/2001WO2001021632A1 Method for nucleic acid isolation and kit
03/29/2001WO2001021310A2 Device for rapid dna sample processing with integrated liquid handling, thermocycling, and purification
03/29/2001WO2001021215A1 Cell based assay
03/29/2001WO2001021202A2 Treatment of chronic inflammatory disease by inhibiting sub-groups of activated t-cells
03/29/2001WO2001021193A1 Hybrid peptides modulate the immune response
03/29/2001WO2001020998A1 Drug discovery using gene expression profiling
03/29/2001WO2001002557A8 Neurotrophic factor receptor
03/29/2001WO2001000843A3 Corynebacterium glutamicum genes encoding metabolic pathway proteins
03/29/2001WO2000077026A8 49 human secreted proteins
03/29/2001WO2000067037A8 A combined rapid anti-microbial susceptibility assay and microorganism identification system
03/29/2001WO2000063439A3 Shot-gun sequencing and amplification without cloning
03/29/2001WO2000050632A3 Polymorphic dna fragments and uses thereof
03/29/2001WO2000042838A3 Molecular profiling for heterosis selection
03/29/2001WO2000032823A9 Dna-protein fusions and uses thereof
03/29/2001WO2000032775A9 Pth1r and pth3r receptors
03/29/2001WO2000031290A9 Methods and compositions for pain management
03/29/2001WO2000023615A3 Method for extracting quantitative information relating to an influence on a cellular response
03/29/2001WO1999066068A3 Method and kit for detecting resistance to antiviral drugs
03/29/2001DE19962508A1 Verfahren zur Identifizierung von MHC-Restringierten Antigenen A method for identifying of MHC-restricted antigens
03/29/2001DE19946296A1 Multiplex-PCR zum Nachweis von EHEC-Infektionen Multiplex PCR for detection of EHEC infections
03/29/2001DE19944870A1 Signalsequenzen zur Herstellung von Leu-Hirudin über Sekretion durch E. coli in das Kulturmedium Signal sequences for preparing Leu-hirudin by E. coli via secretion into the culture medium
03/29/2001DE19944226A1 Verfahren zum Nachweis von oxidierten Formen der löslichen Guanylatzyklase und Verfahren zum Screening nach Aktivatoren der löslichen Guanylatzyklase mit oxidiertem Hämeisen Method for the detection of oxidized forms of the soluble guanylate cyclase and method of screening for activators of soluble guanylate cyclase with oxidized heme iron
03/29/2001DE19943374A1 Verfahren zum Anbinden von Nukleinsäuren an eine Festphase Mechanism for attaching nucleic acids to a solid phase
03/29/2001CA2387695A1 A novel member of the heparanase protein family
03/29/2001CA2385920A1 Assay